Status:
UNKNOWN
Prevention of Liver Damage During Liver Surgery
Lead Sponsor:
Ludwig-Maximilians - University of Munich
Conditions:
Liver Tumors
Phase:
PHASE1
PHASE2
Brief Summary
Liver damage as a consequnce of ischemia (I) and reperfusion (R) is known to harm the liver and could hence be a critical factor of the postoperative outcome of patients undergoing liver surgery. In o...
Eligibility Criteria
Inclusion
- elective resection of liver tumors
- age 18 to 80 years
- informed consent
Exclusion
- chronic obstructive pulmonary disease
- heart insufficiency NYHA III-IV
- atrio-ventricular conductance blockage II. (Mobitz) or III. degree
- atrial fibrillation
- coronary heart disease (CCS III. or IV. degree)
- arterial hypertension
- acute renal failure
- increased intracranial pressure
- gout
- pregnancy
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00845689
Last Update
February 18 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.